Philips and Inspira Health announce USD 50 million, long-term strategic partnership to transform patient care for residents o...
December 02 2019 - 12:00PM
Philips and Inspira Health announce USD 50 million, long-term
strategic partnership to transform patient care for residents of
southern New Jersey, U.S.
December 2, 2019
Leading health system leverages Philips diagnostic imaging and
patient monitoring solutions to deliver on Quadruple Aim: better
outcomes, increased efficiency, and improved patient and staff
experience
Andover, U.S. and Mullica Hill, U.S.
– Royal Philips (NYSE: PHG, AEX: PHIA), a global
leader in health technology, and Inspira Health (Inspira), today
announced a strategic 5-year partnership agreement worth USD 50
million to standardize patient monitoring and drive innovation in
diagnostic imaging solutions in order to enhance patient care and
improve clinical workflow performance. The agreement will make
Philips solutions available to more than a dozen Inspira health
facilities, helping the charitable non-profit fulfill its
commitment to provide access to the highest quality medical
services. The contract also includes training and services that
will maximize Inspira’s operational efficiency.
Inspira is the region’s leading network of health care
providers, delivering the full continuum of primary, acute and
advanced care services. The health system is comprised of three
hospitals, a comprehensive cancer center, several multi-specialty
health centers and a total of more than 150 access points. The
health network is also opening a state-of-the-art hospital this
month and an adjacent leading-edge cancer center in January in
Mullica Hill, New Jersey. Both will incorporate Philips technology
to create an integrated care facility centered around patient
needs.
Long-term strategic partnerships (LSPs) are a growing trend used
within hospitals and health systems to better manage the cost and
complexity of their technology investments over a defined period,
while expanding quality access to advanced medical care in order to
improve patient outcomes. Philips is a leader in LSPs and will
provide Inspira with the latest in diagnostic imaging solutions,
patient care monitoring systems, and minimally invasive solutions
such as the Philips Azurion image-guided therapy platform. Driven
by benefits for patients and care providers, minimally invasive
therapies such as the catheter-based treatment of certain tumors,
aneurysms, obstructed blood vessels, heart rhythm disorders and
defective heart valves continue to grow fast. These therapies are
also more cost-effective and support Inspira’s vision of providing
quality care for its communities, with a focus on cancer and
cardiac care.
“At Inspira, we are focused on leveraging technology that
enables our teams to provide the best possible care. By working
closely with Philips, we have an opportunity to stay at the cutting
edge of imaging and patient monitoring,” said John DiAngelo,
president and CEO, Inspira Health. “This partnership will bring
countless benefits to our patients, physicians and clinical teams.
It comes down to ensuring that each individual community within our
broader community is taken care of.”
Long-term strategic partnerships also provide forward-thinking
organizations like Inspira with a predictable and stable financial
model, while helping to take the guesswork out of technology
adoption. It will allow Inspira to standardize its diagnostic
imaging and patient monitoring technologies across the network,
making data more integrated and allowing clinicians to get access
to the right patient data, which will facilitate better diagnosis
and treatment.
“At Philips we want to improve the lives of 3 billion people a
year by 2030. In order to achieve that goal, we need to work
closely with forward-thinking health systems like Inspira that can
help us to understand the unique challenges of the communities it
serves and deliver the right care solutions,” said Vitor Rocha,
Chief Market Leader, Philips North America. “Together we can help
achieve the Quadruple Aim and focus on what is most important –
providing the best quality care for patients.”
Philips and Inspira announced the new partnership at the
Radiological Society of North America 2019 Annual Meeting where
Philips is showcasing the power of precision diagnosis with
clinical capabilities, simplified workflows and integrated
artificial intelligence.
For more information about Inspira Health, visit
www.inspirahealthnetwork.org.
For further information, please contact:
Silvie CasanovaPhilips North AmericaTel: +1 781 879 0692Email:
silvie.casanova@philips.com
Mark GrovesPhilips Global Press OfficeTel: +31 631 639 916Email:
mark.groves@philips.comTwitter: @mark_groves
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2018
sales of EUR 18.1 billion and employs approximately 80,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
About Inspira Health Network Inspira Health is
a charitable nonprofit health care organization and a regional
leader in physician training, with approximately 160 medical
residents and fellows in nine nationally accredited specialty
programs. The system, which traces its roots to 1899, comprises
three hospitals, a comprehensive cancer center, several
multi-specialty health centers and a total of more than 150 access
points. These include urgent care; outpatient imaging and
rehabilitation; sleep medicine labs; cardiac testing facilities;
digestive health and wound care centers; home care and hospice; and
more than 30 primary and specialty physician practices in
Gloucester, Cumberland, Salem, Camden and Atlantic counties.
Together with its medical staff of more than 1,300 physicians and
other care providers, as well as more than 6,000 employees, Inspira
Health provides evidence-based care to help each patient achieve
the best possible outcome. Accredited by DNV Healthcare, the
system’s clinical and support staffs are focused on providing
quality care in a safe environment. For more information about
Inspira Health, visit www.InspiraHealthNetwork.org or
call 1-800-INSPIRA.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024